Orasis Pharmaceuticals

Developer of reformulated eye drops for the treatment of Presbyopia

placeHerzliya, Tel Aviv, Israel calendar_todayFounded 2015 groups24 employees language orasis-pharma.com

Social engagement

Social engagement: 8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Bluestem Capital, Visionary Ventures, Sequoia Capital, Maverick Ventures.

Investor typeCountShare
Venture capital1091%
Private equity19%

Recent activity

24 Jun 2026
Event
optometry meetings nationwide
20 May 2026
Product launch
presbyopia drop
Coming soon